In his first address to a joint session of Congress April 28, President Joe Biden made a pitch for significantly increasing federal funding for biomedical research, especially cancer research—a cornerstone of his jobs plan.
Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019).
